Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02440672 · ClinicalTrials.gov registry record

JOURNEY™ II CR Total Knee System

A clinical trial of Osteoarthritis, Knee, sponsored by Smith & Nephew.

Active
Registry status
170
Enrollment target
9
Study locations

NCT02440672: Active study of Osteoarthritis, Knee, sponsored by Smith & Nephew.

NCT02440672 is a study of Osteoarthritis, Knee that is active but no longer recruiting, run by Smith & Nephew. The registered enrollment target is 170 participants, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (66% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02440672, a study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by Smith & Nephew.

ACTIVE NOT RECRUITING
Registry status
170 participants
Enrollment target
9
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the JOURNEY™ II CR Total Knee System in subjects with degenerative joint disease (DJD) requiring primary total knee replacement.

Conditions Studied

Interventions

  • DEVICE JOURNEY™ II CR Total Knee System (J II CR TKS)

Study Locations (9)

Other

  • Hospital Parc Taulí Servei de Cirurgia Ortopèdica I Traumatologia - Barcelona
  • Royal National Orthopaedic Hospital NHS Trust - Stanmore
  • Barts Health NHS Trust - Whitechapel

Arizona

  • Orthopedic Institute of the West - Phoenix

Illinois

  • Rush University Medical Center - Chicago

Maryland

  • Anne Arundel Health System Research Institute, Inc - Annapolis

New York

  • Center for Hip and Knee Replacement at Columbia University Medical Center - New York

North Carolina

  • Wake Forest University - Winston-Salem

Ohio

  • The Lindner Research Center, Musculo-Skeletal Division - The Christ Hospital Health Network - Cincinnati

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2015-09
Est. Completion 2028-06
Smith & Nephew

72 total trials

What the registry record for NCT02440672 still lists

NCT02440672 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (66% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which JOURNEY™ II CR Total Knee System (J II CR TKS) is the first listed.

NCT02440672 lists 9 locations in 7 states (Other, Arizona, Illinois).

Frequently Asked Questions

What is clinical trial NCT02440672 about?

NCT02440672 is a clinical study titled "JOURNEY™ II CR Total Knee System". The purpose of this study is to evaluate the safety and effectiveness of the JOURNEY™ II CR Total Knee System in subjects with degenerative joint disease (DJD) requiring primary total knee replacement.

What is the current status of trial NCT02440672?

This trial is currently active not recruiting. The enrollment target is 170 participants. The study started on 2015-09. Estimated completion is 2028-06.

What conditions does trial NCT02440672 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT02440672?

The interventions under investigation include: JOURNEY™ II CR Total Knee System (J II CR TKS) (DEVICE).

Who is sponsoring clinical trial NCT02440672?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02440672 being conducted?

This trial has 9 study locations across Arizona, Illinois, Maryland, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02440672's enrollment target sits among peer trials

170 41st of 112 higher than 72 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02440672, the US trial registry maintained by the National Library of Medicine. NCT02440672 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.